The Immunoglobulin IgD and IgE Typing Urine Test is a specialized diagnostic assessment performed to measure the levels of IgD and IgE antibodies in the urine. These immunoglobulins play crucial roles in the body's immune response. IgD is less understood but is believed to be involved in the activation of B cells, while IgE is primarily associated with allergic reactions and the defense against parasitic infections. Elevated levels of these antibodies can indicate various health conditions, including allergies, autoimmune diseases, and certain types of infections.
This test is particularly useful for individuals experiencing symptoms that suggest an allergic reaction, immune system disorders, or for those with a family history of such conditions. It can provide valuable information for the diagnosis and management of related diseases.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the Immunoglobulin IgD and IgE Typing Urine Test is 1970 AED. Patients are advised to consult with their healthcare provider for proper interpretation of the test results and to discuss the best course of action based on the findings.
The Methylguanine Methyltransferase (MGMT) test is a specialized diagnostic procedure performed to assess the methylation status of the MGMT gene promoter in tumor cells, particularly in glioblastoma, a type of brain tumor. Methylation of the MGMT gene promoter can inhibit the gene's expression, impacting the effectiveness of certain chemotherapy agents. By evaluating the MGMT methylation status, healthcare professionals can tailor cancer treatment plans more effectively, potentially enhancing the therapeutic outcomes for patients.
This test holds significant value in the field of oncology, guiding decisions regarding the use of alkylating agents in chemotherapy regimens. It is particularly crucial for patients with certain types of brain tumors, where treatment customization can lead to improved survival rates and quality of life.
In the United Arab Emirates, this test is available at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the MGMT test at DNA Labs UAE is set at 1970 AED. Given the complexity and the specialized nature of this test, it represents a critical investment in the precision medicine approach to cancer treatment, offering hope for more effective and personalized therapy plans for patients facing challenging diagnoses.
The MICM Maternally Inherited Cardiomyopathy Mutation Detection Test is a specialized genetic screening designed to identify mutations associated with maternally inherited cardiomyopathies. This advanced diagnostic tool is crucial for detecting genetic markers that indicate a predisposition to various forms of heart muscle disorders, which are passed down from mother to child. Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers individuals the opportunity to understand their genetic risk for developing cardiomyopathies, enabling early intervention and personalized management strategies.
Priced at 1970 AED, the test is accessible for those who are looking to take proactive steps in managing their heart health, especially if they have a family history of cardiomyopathy or related heart conditions. By analyzing specific DNA segments, the test can pinpoint mutations that contribute to the development of these heart disorders, providing invaluable information for patients and their healthcare providers. This information not only aids in the early detection and treatment of cardiomyopathy but also helps in the guidance of family planning decisions for those who may carry the genetic markers.
The MMC Maternal Myopathy with Cardiomyopathy Mutation Detection Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying specific genetic mutations associated with maternal myopathy and cardiomyopathy. This test plays a crucial role in the early detection and management of these conditions, which can have significant implications for maternal health during pregnancy and the postpartum period. Myopathies are disorders affecting muscle function, and cardiomyopathies involve the deterioration of the heart muscle, potentially leading to heart failure. The detection of relevant mutations through this test allows for personalized medical advice, interventions, and monitoring to mitigate health risks for both the mother and the child.
Priced at 1970 AED, the test is conducted in a state-of-the-art laboratory setting by DNA Labs UAE, ensuring high standards of accuracy and reliability. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for genetic markers associated with maternal myopathy and cardiomyopathy. Results from this test can provide essential insights into the patient's genetic predisposition to these conditions, facilitating informed decisions regarding pregnancy planning, healthcare, and lifestyle adjustments to support optimal maternal and fetal outcomes.
Prader-Willi Syndrome (PWS) is a rare genetic disorder characterized by a range of physical, mental, and behavioral problems. A key feature of PWS is a constant sense of hunger, leading to chronic overeating and obesity. The syndrome results from abnormalities in chromosome 15, where specific genetic markers are either missing or unexpressed.
The Methylation Specific PCR (MSP) test is a crucial diagnostic tool for identifying Prader-Willi Syndrome. This test focuses on detecting abnormal methylation patterns in the DNA associated with PWS. Methylation is a chemical modification of DNA that can affect gene expression without changing the DNA sequence. In the case of PWS, certain regions on chromosome 15 undergo abnormal methylation, leading to the syndrome's manifestation.
DNA Labs UAE offers this specialized MSP test for Prader-Willi Syndrome, providing a reliable means of diagnosis for families and individuals at risk. The test cost is set at 1970 AED. By conducting this test, healthcare providers can accurately diagnose PWS, enabling early intervention and management strategies to improve the quality of life for those affected by the syndrome.
The Sperm DNA Fragmentation (DFI) Test is a crucial diagnostic tool offered by DNA Labs UAE, aimed at evaluating male fertility potential. This test specifically measures the percentage of sperm cells that have fragmented or broken DNA, which can be a significant factor in understanding unexplained infertility, recurrent miscarriage, or failed IVF attempts. DNA fragmentation in sperm can be caused by various factors, including oxidative stress, lifestyle choices, infection, fever, and exposure to environmental and chemical toxins.
With a test cost of 1970 AED, the Sperm DNA Fragmentation DFI Test is conducted with precision and care at DNA Labs UAE, utilizing advanced technology to ensure accurate and reliable results. This information is critical for couples facing challenges in conceiving, as it can guide healthcare providers in recommending appropriate treatments or interventions to improve fertility outcomes. DNA Labs UAE offers this specialized service as part of its commitment to providing comprehensive fertility assessments, supporting individuals and couples on their journey to parenthood.
The Fragile X FMR1 Mutation Screen Test is a specialized genetic test designed to detect mutations in the FMR1 gene, which is associated with Fragile X syndrome. This condition is a genetic disorder that causes a range of developmental problems including learning disabilities and cognitive impairment. The test is crucial for individuals with a family history of Fragile X syndrome or for those showing symptoms of the disorder. By analyzing a sample of DNA, usually obtained from a blood draw, this test can identify variations in the CGG triplet repeat in the FMR1 gene that are indicative of Fragile X syndrome.
At DNA Labs UAE, this comprehensive testing service is offered for 1600 AED. The laboratory employs state-of-the-art genetic testing technologies to ensure accurate and reliable results. Conducting the test in a controlled environment under the supervision of experienced geneticists and technicians guarantees the highest standard of diagnostic precision. This test not only aids in the diagnosis of Fragile X syndrome but also plays a pivotal role in guiding the management and treatment of individuals affected by the condition. Furthermore, it can provide essential information for families considering their future reproductive options.
The "Galactosemia GALT Gene Mutation Detection Test" is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the GALT gene, which are responsible for galactosemia. Galactosemia is a genetic disorder that affects an individual's ability to metabolize the sugar galactose properly. The condition can lead to various health issues, including liver damage, growth problems, and intellectual disabilities if not diagnosed and managed early.
This test is crucial for early detection, enabling timely intervention and management to mitigate the adverse effects of the disorder. By analyzing DNA samples, the test identifies specific mutations in the GALT gene that are indicative of galactosemia, providing essential information for healthcare providers to develop an appropriate treatment plan.
Offered at a cost of 1600 AED, the test at DNA Labs UAE represents a significant step forward in the genetic diagnosis and management of galactosemia, offering hope and improved outcomes for affected individuals and their families.
The Amino Acids Quantitative Urine and Plasma 45 Amino Acids Full Panel Test, offered at DNA Labs UAE, is a comprehensive diagnostic assessment designed to evaluate the levels of 45 different amino acids in both urine and plasma samples. This test is crucial for detecting abnormalities in amino acid metabolism, which can indicate a variety of health issues ranging from nutritional deficiencies to more serious metabolic disorders. By analyzing the concentration of amino acids, healthcare providers can gain insights into a patient's metabolic state, helping in the diagnosis, management, and treatment planning of conditions such as aminoacidurias, organic acidurias, and urea cycle disorders. The cost of this extensive panel is 1940 AED, reflecting its value in providing a detailed overview of an individual's amino acid profile for medical evaluation and intervention.
The "FISH - MDS Panel - Chromosomes 5q, 7q, 8q, and 20q Test" is a specialized diagnostic examination offered by DNA Labs UAE, aimed at individuals suspected of having Myelodysplastic Syndromes (MDS) or related chromosomal abnormalities. This test employs Fluorescence In Situ Hybridization (FISH), a powerful cytogenetic technique that allows for the visualization of specific DNA sequences on chromosomes. By focusing on chromosomes 5q, 7q, 8q, and 20q, the test targets regions frequently associated with alterations in MDS cases. These chromosomal abnormalities can provide critical information regarding prognosis, potential response to therapy, and can also guide treatment decisions. The cost of the test is 1920 AED, reflecting the sophisticated technology and expertise required to perform this analysis. Through its precise targeting and the detailed genetic insights it offers, the test represents a valuable tool in the personalized management of MDS, enabling healthcare providers to tailor treatments to the unique genetic profile of each patient.
